Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring
Capricor Therapeutics (CAPR) Soars on Promising FDA Discussions: Is This a…
EMCORE (EMKR): A Takeover Target? Mobix Labs’ Bold Bid Shakes Things…
Telesis Bio Partnership with Beckman Coulter: A Potential Game-Changer for Synthetic…
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
EMED
Tag: EMED
Top Medical Device Biotech Growth Stocks Catch Fire (SWAV, EMED, IRTC,...
Ash K
-
August 18, 2022
0
Recession-Proof Medical Device Space Looks Ahead at Accelerating Growth Potential (TIVC,...
Matt Wade
-
May 24, 2022
0
How Decentralized Healthcare Could Spawn Coming Boom in Medical Device Stocks...
Ward Sport
-
April 7, 2022
0
Medical Device Stocks in Sweet Spot as Correction Creates Historic Opportunity...
Gavins Felicity
-
March 9, 2022
0
Stocks to Battle the Opioid Epidemic (NVRO, AXSM, EMED, MDT)
Gavins Felicity
-
September 18, 2020
0
1
2
Page 1 of 2
Recent Post
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
Kate Hudson
-
October 10, 2024
0
GNTA stock closed with a significant jump of 21.40% today, reaching $6.92 at the closing bell. This surge was fueled by exciting...
WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring
October 10, 2024
Capricor Therapeutics (CAPR) Soars on Promising FDA Discussions: Is This a...
October 1, 2024
EMCORE (EMKR): A Takeover Target? Mobix Labs’ Bold Bid Shakes Things...
October 1, 2024
Telesis Bio Partnership with Beckman Coulter: A Potential Game-Changer for Synthetic...
September 26, 2024
